John Ioannidis
Academic Appointments
- Professor, Medicine - Stanford Prevention Research Center
- Member, Stanford Cancer Institute
- Professor, Health Research & Policy - Epidemiology
- Professor (By courtesy), Natural Sciences Cluster - Statistics
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 725-5465Alternate Contact Marci Palacios Assistant to the Director Email Tel Work 650-7255465
Professional Overview
Administrative Appointments
- C.F. Rehnborg Professor in Disease Prevention and Director, Stanford Prevention Research Center (2010 - present)
- Professor of Medicine, Stanford University School of Medicine (2010 - present)
- Professor of Health Research and Policy, Stanford University School of Medicine (2011 - present)
- Professor of Statistics (by courtesy), Stanford University School of Humanities and Sciences (2011 - present)
- Affiliated faculty, Woods Institute for the Environment (2011 - present)
- Member, Stanford Cancer Center (2010 - present)
Honors and Awards
- European Award for Excellence in Clinical Science, European Society for Clinical Investigation (2007)
- Executive board member and center director, Human Genome Epidemiology Network (2004-)
- President, Society for Research Synthesis Methodology (2009-2010)
- Elected member, Association of American Physicians (2009-)
- Elected fellow, European Academy of Cancer Sciences (2010-)
Professional Education
| Fellowship: | New England Medical Center, Tufts University School of Medicine, Infectious Diseases (1996) |
| Residency: | New England Deaconess Hospital, Harvard Medical School, Internal Medicine (1993) |
| DSc: | University of Athens School of Medicine, Athens, Greece, Biopathology (1996) |
| MD: | University of Athens School of Medicine, Athens, Greece, Medicine (1990) |
Scientific Focus
Current Research Interests
I have worked in the fields of evidence-based medicine, clinical investigation, clinical and molecular epidemiology, clinical research methodology, empirical research methods, statistics, and genomics. I have a strong interest in large-scale evidence (in particular randomized trials and meta-analyses) and in appraisal and control of diverse biases in biomedical research. I am interested in developing and applying new research methods, and in the interdisciplinary enhancement of existing research methods for study design and analysis in biomedicine. Some of my most influential papers in terms of citations are those addressing issues of replication validity of genetic association studies, biases in biomedical research, research synthesis methods, extensions of meta-analysis, genome-wide association studies and agnostic evaluation of associations, and validity of randomized trials and observational research. I have also designed, steered and participated in influential randomized trials (in particular, the major trials that changed decisively the management and outcome of HIV infection, but also trials in nephrology, and in antibiotic use in the community), and large international consortia that have helped transform the efficiency of research in diverse fields of genomic, molecular and clinical epidemiology. I enjoy working with a diverse array of colleagues from very diverse disciplines and to have an opportunity to learn from both senior and junior investigators, and particularly students at all levels.
Publications
- Are mortality differences detected by administrative data reliable and actionable? JAMA. 2013; (13): 1410-1
- Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. BMJ. 2013: f707
- Mega-trials for blockbusters. JAMA. 2013; (3): 239-40
- Patient safety strategies targeted at diagnostic errors: a systematic review. Ann Intern Med. 2013; (5 Pt 2): 381-9
- A nutrient-wide association study on blood pressure. Circulation. 2012; (21): 2456-64
- Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012; (16): 1676-84
Help